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Abbreviations
ACN     Acetonitrile
ASE     Accelerated solvent extraction
DHE     Di-n-hexyl ether
DMSO    Dimethyl sulphoxide
E      Extraction efficiency
Ee      Enrichment factor
FLU     Fluoxetine
GC     Gas chromatography
HAc     Acetic acid
HF-LPME   Hollow fibre liquid phase micro extraction
LC-DAD   Liquid chromatography with diode array detection
LC-FLD   Liquid chromatography with fluorescent detection
LC-MS    Liquid chromatography with mass spectrometric detection
LC-MS/MS  Liquid chromatography with tandem mass spectrometric detection
LC-UVD   Liquid chromatography with ultra violet detection
LLE     Liquid-liquid extraction
LOD     Limit of detection
LOQ     Limit of quantisation
MDL     Method detection limit
MIP     Molecularly imprinted polymers
NH4AC    Ammonium acetate
NH4H2PO4   Ammonium phosphate
norFLU    Norfluoxetine
NSAID    Non steroidal anti-inflammatory drugs
PLE     Pressurised liquid extraction
PPCP    Pharmaceuticals and personal care products
PQL     Practical quantisation limit
Q-TOF    Quadrupole time of flight mass spectrometer
RSD     Relative standard deviation
SBSE    Stir bar sorptive extraction
SD     Standard deviation
SER     Sertraline
SLME    Supported Liquid Membrane Extraction
SPE     Solid phase extraction
SPME    Solid phase micro extraction
SSRI     Selective serotonin reuptake inhibitor
TEA     Triethylamine
WWTP    Waste water treatment plant
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Abstract
 Selective serotonin reuptake inhibitors (SSRIs) have been found in waste water treatment 
plant effluents and surface water at detectable concentrations. Although the medical effects 
and side effects of pharmaceuticals and personal care products are investigated through safety 
and toxicology  studies the potential environmental impacts are less studied, and information 
concerning ecotoxicological risks and the distribution in sludge, surface water and water 
living organisms is rather scarce. In this thesis, sertraline (SER), fluoxetine (FLU) and its N-
desmethyl metabolite norfluoxetine (norFLU) were chosen as model substances to develop a 
method for detection. Fish was chosen as the model matrix because fish is a top  predator with 
possible high analyte concentrations because of biomagnification. Hollow fibre liquid-phase 
membrane extraction (HF-LPME) was used as the extraction, clean-up and enrichment 
technique and LC-MS was used to detect the SSRIs in fish muscle tissue. This analytical 
method showed enrichment factors ranging 1500-1800 for fish samples and 3000-6300 for 
water samples. The R2-values of the linearity were 0.936, 0.990, 0.966 for norFLU, FLU and 
SER, respectively. The detection limits of the method for norFLU, FLU and SER were in the 
range of 130-280 ng L-1. The method was successfully  applied to detect the analytes in 
exposed crucian carp; 1.7 µg g-1 FLU and 2.8 µg g-1 SER were found after exposure to a 
51 µg L-1-mixture for 3 days. The FLU metabolite norFLU was not added in the exposure 
solution and it  was not formed in detectable concentrations during the exposure. In unexposed 
crucian carp, none of the analytes were detected. The developed analytical method might be 
extended to estimate the distribution or the fate of norFLU, FLU and SER in other biota or 
human beings.
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1. Introduction - SSRI in the environment
 Pharmaceuticals and personal care products (PPCPs) are important as they help in the 
treatment and prevention of disease in both humans and animals. The occurrence and fate of 
PPCPs in the environment have been recognised as major issues because of their growing use 
and unknown environmental impacts [1-6]. When excreted, PPCPs and their metabolites 
reach waste water treatment plants (WWTP), and analysis of effluent waters show that PPCPs 
are not completely removed [7,8], leading to levels of PPCPs in aquatic environments 
reaching at least ng L-1 concentrations at several locations around the world [9,10].
 Depression is among the oldest diseases known to mankind and is among the most serious 
medical diseases, both to society [11] and to the patient and his/her kins [12]. Since the 
introduction of selective serotonin reuptake inhibitors (SSRIs), even milder forms of 
depression are being treated medically [13]. The most commonly prescribed pharmaceuticals 
for psychiatric illnesses belong to the antidepressants group selective serotonin reuptake 
inhibitors (SSRIs) [4,5,14-17], including fluoxetine (FLU), the active compound in 
pharmaceuticals like Fontex and Prozac, and sertraline (SER), active compound in e.g. 
Sertranatl and Zoloft. SSRIs are designed to be highly  active and interact with receptors in 
humans, but they also have unintended effects on animals in the environment [18]. Although 
the effects and side effects of the pharmaceuticals are investigated through safety and 
toxicology studies [19,20], the potential environmental impacts are less studied.
 It has been shown that psychiatric drugs are not completely metabolised by the human 
body and therefor excreted, either as the parent compounds, or as metabolites to wastewater 
[2,20-23]. Even metabolites, such as norfluoxetine (norFLU), an N-desmethyl product of 
FLU, although less potent than the parent compound, can be biologically active 
[17,20,23-26]. Also, SSRIs find their way to aquatic ecosystems through WWTP discharges 
[27] and sludge [28]. Therefore, it is necessary to determine the presence and levels of SSRIs 
in biota. Most of the studies on the fate of pharmaceuticals in WWTPs are focused on 
aqueous samples because biological samples always present a complex matrix with plenty  of 
interferences to be co-extracted. To exclude these interferences to a greater extent, clean-up 
techniques for the determination of SSRIs in biological samples are necessary. Also, the 
enrichment of the analytes is an important step since they are present at trace levels of ng g-1 
[16,20].
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1.2 Sample preparation for SSRIs - a review
 Very  often in analytical chemistry, the analytes are present in a more or less complex 
matrix, the SSRIs of this study  being no exception. Over the years a number of different 
techniques have been employed to clean up  and pre-concentrate the analytes; to remove 
coexisting unwanted substances and to enrich the analytes. The methodology  of choice is 
somewhat dependent both on the physical properties of the sample, the chemical properties of 
the analyte, and availability  of equipment. Therefore, different analytes in different matrices 
may be extracted and analysed by different methods. Below is a review of different 
techniques used, in regard to the matrix.
1.2.1 Sample preparation for SSRIs in water samples
 Aqueous samples are the simplest type of matrix to extract from, with not too many 
interferents available. The most commonly applied extraction technique for aqueous samples 
is solid phase extraction (SPE) combined with either LC-MS/MS [3,16,21,23] or LC-DAD 
[22]. Demeestere et al [4] also used SPE with molecularly imprinted polymers (MIP) to 
analyse SSRI in aqueous samples.
1.2.2 Sample preparation for SSRIs in semi-solid and solid samples
 Semi-solid and solid samples include sewage sludge, soil and sediment. More interfering 
compounds than in aqueous samples are present, why the extraction needs to be more 
efficient. Methods for extraction of SSRIs include SPE followed by  LC-MS/MS [16], SPE 
and liquid-liquid extraction (LLE) followed by LC-MS [15], pressurised liquid extraction 
(PLE), followed by LC-MS [1], and accelerated solvent extraction (ASE) followed by LC-
MS/MS [3]. Because of the more complex matrix, membrane extraction is also popular for 
semi-solid samples, such as liquid phase membrane extraction (LPME) [2,24,28,29] or 
pressurised hot water extraction (PHWE) followed by LPME [28] in combination with either 
LC-MS, LC-MS/MS or LC-DAD.
1.2.3 Sample preparation for SSRIs in biological samples
! Another complex type of matrix is present in biological samples. Common extraction 
techniques are SPE combined with LC-MS/MS [8,30], LC-FLD/UVD [31], or GC-MS 
[32,33], LLE with CG-MS [34] or stir bar sorptive extraction (SBSE) with LC-FLD [35]. 
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Because of the utterly complex matrix, such methodologies as solid phase micro extraction 
(SPME) [36] or membrane extraction are other good ways of excluding interferents.
1.3 Membrane extraction
 In the search for more environmentally  friendly yet efficient  methods, membrane 
extraction is a method that lately  has received growing attention; target analytes are 
selectively extracted, extraction and work up is done in one step, and extracted analytes are 
easily quantitatively transferred to the instrument for final analysis. The use of organic 
solvents is negligible. The benefits of membrane extraction include high selectivity for target 
analytes, high enrichment power, as well as being economical and environmentally friendly 
[37-42].
 In membrane extraction a membrane is used to separate the sample (called the donor 
phase) from the acceptor phase. Target analytes pass from the donor phase, through the 
membrane and into the acceptor, where they  are enriched. Membrane extraction can be made 
with porous and nonporous membranes and in one, two, or three phase configurations. 
Examples of porous one phase techniques are filtration and dialysis, while nonporous 
techniques include two or three phase membrane configurations.
 If either the donor or acceptor phase has the same composition as the membrane, only one 
phase boundary (and one partitioning interface) is created. This is what characterises a two 
phase system. In a three phase system, on the other hand, the donor and acceptor phases are 
separated by the membrane phase, to form two phase boundaries and two partitioning 
interfaces. This membrane phase can be a liquid, a polymer, or a gas. Donor and acceptor 
phases can be either gas or liquid, aqueous or organic. To create a liquid membrane phase, a 
support is needed. This support is often a porous hydrophobic membrane, in whose pores the 
liquid is immobilised. This is called a supported liquid membrane (SLM). Depending on the 
type of analyte, the system will need optimisation by the use of different phases, to maximise 
selectivity and enrichment.
1.3.1 Principles of Supported Liquid Membrane Extraction (SLME)
 If the target analyte is an acid or a base, a three-phase SLM system is a good choice of 
extraction method because of its ability  to enrich the analyte in the acceptor phase. The ability 
of acids and bases to exist both in ionic and nonionic form is crucial for SLME, not only  for 
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the process of enrichment, but also for the selectivity  of the method. Figure 1 illustrates the 
general set up of an SLME. Initially  the analyte is present, along with a lot of interfering 
compounds, in the donor phase. The organic membrane phase, immobilised in the pores of the 
membrane, is usually a solvent of long chain hydrocarbons (n-undecane, kerosene or more 
polar solvents like DHE) for which the analyte has a higher selectivity than for the donor 
phase. The analyte diffuses into the pores and further on, into the acceptor phase in the lumen 
of the membrane. By chemical means, the analytes is altered in the acceptor and thus being 
trapped and enriched inside the fibre.
 Figure 1.  General set up for an SLME: the target analyte diffuses from 
the donor phase, through the membrane phase, and into the acceptor 
phase where it is enriched.
1.3.2 SSRI Hollow Fibre Liquid Phase Membrane Extraction (HF-LPME)
 Hollow fibre liquid phase membrane extraction is a three phase supported liquid extraction 
technique, where the support membrane is a hollow polymer fibre. This technique is a good 
choice for extracting acidic or basic pharmaceuticals. By utilising a pH-gradient, nonionised 
target analytes will diffuse from the donor phase into the organic phase in the pores of the 
membrane. To ionise the analyte is a matter of pKa. In the case of basic compounds, pH in the 
donor phase needs to be well above pKa, and vice versa in the acceptor phase. From the 
organic phase the analyte will continue into the acceptor phase inside the membrane, where it 
4
will be ionised by acid-base reactions and immobilised because of the charged forms inability 
to dissolve in the organic phase. After extraction the analyte is readily  transferred in a 
quantitative way to an analytical instrument. Figure 2 describes the principle of HF-LPME of 
fluoxetine from a pH-adjusted donor. Uncharged FLU readily diffuses into the organic solvent 
in the membrane phase and into the acceptor phase inside the fibre. The low pH of the 
acceptor phase protonates FLU, making it ionic. Once charged, FLU no longer diffuses back 
into the organic solvent, but gets trapped and enriched in the acceptor phase.
 Figure 2.  Principle of HF-LPME of the basic target analyte FLU. pH in 
the donor phase is well above pKa to ensure nonionic analytes. Uncharged 
FLU readily diffuses into the organic solvent in the membrane phase and into 
the acceptor phase inside the fibre. Here, the low pH turns FLU ionic. Once 
charged, FLU will no longer diffuse into the organic solvent, but gets trapped 
and enriched in the acceptor phase.
Sagristá et al. [43] used this technique in 2010 to determine NSAIDs in WWTP sewage 
sludge and in 2012 [28] to determine SSRIs in the same matrix. Huang used this technique in 
2012 [44] to determine NSAIDs in fish. Vasskog et al. [2] used it  to detect SSRI in sewage 
sludge. Even though being an extraction technique on the rise, to the best our knowledge, only 
very few pieces of work [2,14,24,28,29] lend themselves to extracting SSRI with HF-LPME, 
and non to extracting SSRI with HF-LPME from fish.
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1.3.2.1 The enrichment factor
 How well the analyte is concentrated in the acceptor phase, the enrichment, is crucial to the 
efficiency of HF-LPME, and is defined as [38,42]:
Ee =
CAe
CDi
              (1)
where CAe is the analyte concentration in the acceptor phase at equilibrium, and CDi is the 
initial analyte concentration in the donor phase.
 The extraction efficiency (E) of HF-LPME is defined in a similar way [45]:
E = mAemDi
⋅100
m = C ⋅V
⎫
⎬
⎪
⎭⎪
⇒ E = CAe ⋅VACDi ⋅VD
⋅100
and in combination with equation (1):
E = Ee ⋅
VA
VD
⋅100             (2)
where, CAe and mAe are the analyte concentration and mass in the acceptor phase at 
equilibrium, respectively; CDi and mDi are the initial analyte concentration and mass in the 
donor phase, respectively, and VA and VD are the acceptor and donor volumes, respectively.
1.3.2.2. The partition coefficient
 In three phase HF-LPME, the analytes are extracted from the sample solution to the 
acceptor solution, passing through the organic solvent in the membrane phase, see Figure 2. 
As the analyte reaches equilibrium between the three phases, the partition coefficient of 
acceptor-donor, KAD, depends on the conditions of the donor and the acceptor [45]. KAD is 
defined as:
KAD =
CAe
CDe
= mAe ⋅VDmDe ⋅VA
	
 	
 	
 	
 	
 	
 	
 	
 	
 	
 (3)
where CAe and CDe are the analyte concentrations at equilibrium in the acceptor and donor 
phases, respectively, and mAe and mDe are the analyte masses at equilibrium in the acceptor 
and donor phases, respectively.
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 In the same way, the partition coefficient of fish tissue/donor phase, KFD, and membrane 
phase/donor phase, KMD, can be defined as:
KFD =
CFe
CDe
= mFe ⋅VDmDe ⋅mF
	
 	
 	
 	
 	
 	
 	
 	
 	
 	
 (4)
KMD =
CMe
CDe
= mMe ⋅VDmDe ⋅VM
	
 	
 	
 	
 	
 	
 	
 	
 	
 	
 (5)
where CFe, , CDe and CMe are the analyte concentrations at equilibrium in the fish, donor 
phase, and membrane phase, respectively; mFe, mDe and mMe are the analyte masses at 
equilibrium in the fish, donor phase, and membrane phase, respectively, and mF, VD and VM 
are the mass of the fish, the volume of the donor phase and the volume the membrane phase, 
respectively.
1.4 The analytes
 The target analytes of this study are the SSRIs sertraline (SER) and fluoxetine (FLU), plus 
a desmethylated metabolite of FLU; norfluoxetine (norFLU). The most important chemical 
properties of the analytes are compiled in Table 1.
 Table 1. Chemical properties of the target analytes, norFLU, FLU and SER.
Name Structure Mw pKa Log Kow Solubility mg L-1 Ref.
Norfluoxetine 295.12 9.05 4.07 60.3 [24]
Fluoxetine 309.13 10.05 4.05 3.52 [14]
Sertraline 305.07 9.47 5.29 4.07 [14]
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1.5 Aim of this study
 SSRIs have widely been found in WWTP effluents and surface water at different 
concentrations. For example, citalopram, paroxetine, fluoxetine and sertraline were extracted 
from sewage sludge by HF-LPME and analysed by LC/MS by Sagristà et  al. in 2012 [28]. 
Although the medical effects of PPCPs are investigated through safety and toxicology  studies 
[19,20], the potential environmental impacts are less studied, and information concerning 
ecotoxicological risks and the distribution in sludge, surface water and water living organisms 
is rather scarce. Being top predators, fish are especially subjected to high concentrations 
because of biomagnification. To investigate this, a new method which can consecutively 
extract and detect different SSRIs and metabolites in fish is needed. To our knowledge, no 
previous studies for the analysis of SSRIs using HF-LPME in fish have been published.
 The goal of this study is therefore to evaluate HF-LPME as extraction, clean-up and 
enrichment technique followed by LC/MS-analysis for the simultaneous determination of 
norfluoxetine, fluoxetine and sertraline in fish tissue. As far as possible, the method follows 
that of Huang [44]. To adapt the method to fit SSRIs as analytes, the work of Sagristà et al 
[28] was taken into consideration. Ultimately  the work in this thesis could help in providing a 
way to monitor SSRIs in biota.
2. Experimental
2.1 Chemicals and reagents
 Fluoxetine hydrochloride, sertraline hydrochloride, norfluoxetine hydrochloride, 
dihexylether (DHE), ammonium acetate (NH4AC) reagent grade were obtained from Sigma-
Aldrich Chemie GmbH (Steinheim, Germany). Acetonitrile (ACN) gradient grade was 
obtained from Honeywell B&J brand (Sleeze, Germany). Reagent sodium hydroxide was 
obtained from Scharlau Chemie S.A. (Barcelona, Spain). Acetic acid glacial (HAc), 
phosphoric acid (85 % pure) and ammonium phosphate reagent grade were purchased from 
Merck (Darmstadt, Germany). Dimethyl sulphoxide (DMSO) was purchased from Thermo 
Scientific (Rockford, IL, USA). Ultra-pure water was produced by a MilliQ water purification 
system (Millipore, Billerica, MA, USA), and was used throughout the experiments.
 Individual stock standard solutions containing 100 mg L-1 of fluoxetine and sertraline and 
80 mg L-1 of norfluoxetine were prepared in DMSO. For the optimisation and application of 
the methods, firstly  a stock solution containing 10 mg L-1 each of all three SSRIs studied was 
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prepared in water, secondly  working solutions of this mixture were prepared by appropriate 
dilution in water. Calibration curves for LC/MS were prepared by  diluting the mixture in the 
acceptor phase used for HF-LPME. The HF-LPME acceptor buffer was 0.1 M ammonium 
phosphate solution, pH 2.1. The organic phase was DHE. The LC mobile phase buffer was 
0.01 M ammonium acetate, pH adjusted to 4 with acetic acid, 6.5 M. Solutions with a high 
DMSO content were stored in darkness at ambient temperature, all other solutions in darkness 
at 4 ºC to prevent photo degradation of the analytes.
2.2 Fish tissue samples
 Cod (Gadus morhua) was chosen as the fish used for developing the method. A fresh cod 
was purchased locally and stored at -18 ºC.
 Crucian carp (Carassius carassius) was chosen for validating the developed method. Live 
young crucian carps were collected from an unexposed pond on the Revinge field, Lund, 
Sweden.
2.3 Sampling
2.3.1 Spiked water samples
 While optimising the LC-MS method, and to investigate the matrix effect, spiked water 
was used. The water samples were spiked with 10 mg L-1 stock solution, resulting in CDis of 
0.2, 0.5, 0.8, 2, 4, 10, 20, 100 and 200 µg L-1.
2.3.2 Spiked cod samples
 During early development of the method frozen fresh cod was used. An appropriate mass 
of cod muscle tissue from the side of the fish was mixed with an equal mass water. The 
mixture was homogenised for 10 minutes using a Polytron mixer (Kinematica GmbH, 
Lucerne, Switzerland), see Figure 3. 1.0 g samples of the fish mixture were placed in brown 
wide mouth bottles, spiked, and homogenised another 2 minutes with 19.5 mL of water. This 
slurry was left to equilibrate overnight, before 30 mL of water was added and stirred with 
magnetic stir bars for extraction.
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 Figure 3. The fish/water mixture was homogenised for 10 
minutes using a Polytron mixer.
 Later on lyophilised cod was used. Muscle tissue from the fish was cut into pieces of 
approximately 0.5 g each. These samples were lyophilised for 24 h before put in brown wide 
mouth bottles, spiked and homogenised for 10 minutes with 20 mL of water. This slurry was 
left to equilibrate overnight, before 30 mL of water was added and stirred with magnetic stir 
bars for extraction.
2.3.3 Exposed crucian carp samples
 Crucian carp was acclimatised in the lab environment for four weeks in a flow-through tap 
water system before transferred into a 40 L tank where they were exposed to 51 µg L-1 of FLU 
and SER. After three days the fish was removed from the water, decapitated, and wiped with a 
Kleenex tissue.
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 The young crucian carp  is a rather small fish, of approximately  2.5 g each, why the heads 
were removed and put in a batch of their own. The rest of the fish was cut into small pieces 
and randomised, packed in portions of approximately  0.5 g each. These samples were 
lyophilised for 24 h before put in brown wide mouth bottles and homogenised for 10 minutes 
with 20 mL of water. This slurry was left to equilibrate overnight, before 30 mL of water was 
added and stirred with magnetic stir bars for extraction.
2.4 LC-MS method
 Analysis was performed on a Micromass ZMD single quadrupole mass spectrometer 
(Micromass Ltd, Manchester, UK) with an electrospray interface connected to an Agilent 
Hewlett Packard Series 1100 HPLC system, consisting of degasser, pump and auto sampler 
(Hewlett Packard, Karlsruhe, Germany). Injection volume was 4 µL for all samples, using 
needle wash between each pick up, and flow rate was 0.3 mL min-1. The ZMD was controlled 
by MassLynx 4.0 software (Micromass Ltd, Manchester, UK), whether as the HPLC system 
was controlled by a Hewlett Packard remote control. The ZMD was run in positive-ion mode, 
with capillary  voltage 3.6 kV, cone voltage 10 V for norFLU and 15 V for FLU and SER. ESI 
source block temperature was 150 °C, desolvation temperature 350 °C, desolvation gas N2 at 
a flow of 540 Lh-1. Further settings were: extractor voltage 5 V, ion energy 0.9 eV, Rf lens 
voltage 0.2 V, low mass resolution 17.5, high mass resolution 9.1, and multiplier 672. 
Selective ion monitoring was used to detect ions with m/z ratios of 296 (norFLU), 310 (FLU) 
and 306 (SER).
 The chromatographic separation was performed on a Thermo Scientific ODS-2 Hypersil 
column with particle size 5 µm, 2.1×250 mm (Thermo Scientific, Waltham, MA, USA). 
Mobile phases used were A (ACN:NH4AC buffer 5:95) and B (ACN:NH4AC buffer 95:5). To 
increase separation and shorten runtime a gradient  was used, see Table 2. A calibration curve 
was acquired using standard solution of the three analytes of concentrations 0, 1000, 3000, 
5000, 7500 and 10000 µg L-1. To test repeatability  of the method, a standard solution of the 
three analytes (4000 µg L-1) was analysed three times before sample analysis.
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 Table 2. Mobile phases and gradient for the chromatographic separation of norFLU, FLU and SER on a 
Thermo Scientific ODS-2 Hypersil column with particle size 5 µm, 2.1×250 mm. Gradient curve indicates the 
slope of the curve, where 1 is no slope and 6 is 50% slope.
Time (min) Mobile phase A (%) Mobile phase B (%) Flow (mL min-1) Gradient curve*
0.0 50 50 0.3 1
0.5 60 40 0.3 6
2.0 60 40 0.3 1
2.1 50 50 0.3 6
9.0 50 50 0.3 1
2.5 HF-LPME method
 The hollow fibre membranes used were PP50/280 Accurel polypropylene with a wall 
thickness of 50 µm, 0.1 µm pore size and inner diameter of 280 µm (Membrana GmbH, 
Wuppertal, Germany). The fibre was cut into 20 cm long pieces to carry  approximately 10 µL 
of acceptor phase. Each fibre was filled with fresh acceptor buffer using a 0.5 mL (29G x 1/2” 
- 0.33 x 12 mm) Myjector syringe (Terumo Medical Corporation, Elkton, MD, USA), see 
Figure 4a. The fibre was sealed by melting its ends on an electric soldering iron. The fibre 
was immersed in DHE for 1 min to let the pores saturate with organic solvent, and then 
washed in water for 30 sec (Figure 4b) before being tied into a loop, attached to a copper wire 
(Figure 5a) and put into the brown wide mouth bottles containing the donor phase (Figure 5b). 
Extraction parameters were as follows: 50 mL samples at pH 12.4 with NaOH were stirred at 
660 rpm using magnetic stirrer (RO 10 Power, IKA Werke, Staufen, Germany) for 5 h.
 After extraction, the fibre was picked out from the samples, gently  wiped with a Kleenex® 
tissue and both ends were cut open using a scalpel. The acceptor phase was evacuated by an 
air filled syringe into a 2 mL vial with µL inset. The volume of acceptor was determined by 
the mass difference of the vial prior to and after the filling. The samples were immediately 
taken to final analysis.
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 Figure 4a. The hollow fibre membrane was cut 
into 20 cm long pieces and filled fresh acceptor 
buffer. The ends were sealed by melting...
 Figure 4b. ...and then the fibre was immersed in 
DHE for 1 min to let the pores saturate with organic 
solvent, and then washed in water for 30 sec.
 Figure 5a.  When filled with acceptor phase, 
sealed and pores saturated with organic solvent, the 
fibre was tied into a loop, attached with a copper 
wire…
 Figure 5b. ...and put into the brown wide mouth 
bottles containing the samples for 5 h extraction at 
660 rpm.
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3. Results and discussion
3.1 Optimisation of methods
 Optimisations of the method were adapted from Sagristà et al. [28]; HPLC mobile phase 
ACN and NH4AC buffer at pH 4 and donor phase pH 12.4. For the trapping and enrichment 
inside the fibre to take place, protonation of amines need to take place, therefore NH4H2PO4 at 
pH 2.1 was chosen as acceptor phase. Extraction optimisations were adapted from Huang 
[44]; extraction time 5 h, sampling solvent water and the fish to be lyophilised.
3.1.1 LC separation
 Several instrument setups were tested in order to optimise the chromatographic separation 
of the three analytes norFLU, FLU and SER. An Alliance Waters 2695 Separations Module 
(Waters, Milford, MA, USA) with the Thermo Scientific ODS-2 Hypersil column, in 
connection with the Micromass ZMD achieved the best chromatographic separation (Figure 
6). This setup was also fully compatible with the MassLynx 4.0 software. However, the needle 
of Waters 2695 is constructed so that it picks up sample on the side, some 5 mm up from the 
needlepoint, rather than at the point itself, and thus is unable to reach a sample less than 50 
µL of volume (Figure 7).
 Figure 6. The Alliance Waters 2695 Separations Module with the Thermo Scientific ODS-2 
Hypersil column, in connection with the Micromass ZMD achieved the best chromatographic 
separation. TIC of 3 channels (296, 306 and 310) of a calibration solution containing 10 mgL-1 
each of norFLU (tR = 4.58 min), FLU (tR = 5.33 min) and SER (tR = 6.67 min).
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 Figure 7. The Waters 2695 Separations module 
needle is constructed so that it picks up sample on the 
side, some 5 mm up from the needlepoint, rather than at 
the point itself, from [46].
 Two different Agilent Hewlett  Packard Series 1100 HPLC systems, both with the Thermo 
Scientific ODS-2 Hypersil column, in connection with Hewlett Packard Series 1100 MSD, 
were discarded because of being old and out of order. An advantage with this setup, however, 
was the compatibility with the ChemStation Rev. B.01.01 software (Agilent Technologies, 
Santa Clara, CA, USA).
 In the end a third Agilent Hewlett  Packard Series 1100 HPLC system was connected to the 
Micromass ZMD, along with the Thermo Scientific ODS-2 Hypersil column. The HPLC 
system would not communicate with the MassLynx 4.0 software, and therefore MassLynx 
was used to control the ZMD and the HP 1100 remote to control the HPLC. The same 
separation as with the Waters 2695 was never achieved with the HP 1100, but with the LC-
MS setup this is not necessary  as long as the masses are separated in the MS (Figure 8). In the 
end the total runtime for the separation was nine minutes.
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 Figure 8. TIC of 3 Channels (296, 306 and 310), top, and SIRs of the individual channels. HP 1100 Series,  
with Thermo Scientific ODS-2 Hypersil column, in connection with the Micromass ZMD of a calibration 
solution containing 10 mgL-1 each of norFLU (tR = 4.53 min), FLU (tR = 4.97 min) and SER (tR = 5.81 min).
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3.1.2 Calibration curves
 Calibration data of the LC/MS method (as described in 3.1.1) were processed and 
calibration curves for each compound were constructed with R2-values of 0.936, 0.990, 0.966 
for norFLU, FLU and SER, respectively.
3.2 Optimisation of extraction
3.2.1 The matrix effect
 Biological samples do always present a more complex matrix than do water samples, 
therefore it is of interest to investigate how much the matrix interacts with the analytes. 
Spiked water and spiked lyophilised cod were extracted for 5 h with 8 replicates. The overall 
Ee was in the range of 1507-1805 for the cod samples and 3020-6287 for the water samples, 
graphically illustrated in Figure 9.
 Figure 9. Comparing spiked water samples with spiked cod samples: the matrix effect 
is significant, possibly because of physical and or chemical binding of the analytes to the 
proteins in the fish.
 The matrix effect is obvious; analytes in water were enriched to a much greater extent, 
speculatively because of physical and or chemical binding to proteins or lipid tissue in the 
fish, which would decrease the amount of free analytes in the water phase. Or because of fish 
tissue physically getting in the way for the analytes diffusing into the fibre, which would only 
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increase the time for equilibration, i.e. extraction time, and since extraction time was actually 
not optimised (see 3.1) this cannot completely be ruled out.
3.3 Method validation
3.3.1 Repeatability and reproducibility
 To evaluate the validation of the HF-LPME method for norFLU, FLU and SER after 5 h of 
extraction, the repeatability  and reproducibility  (intra-day  precision) spiked water was tested. 
The results, expressed as relative standard deviation, are presented in Table 3.
 Table 3. Method repeatability and reproducibility (n=3) as relative standard deviations for water with a 
spiked concentration of 4000 µg L-1.
Analyte Repeatability (%) Reproducibility (%)
norFLU 100.9 29.3
FLU 34.8 7.4
SER 45.8 21.1
 The range of repeatability were 34.8-100.9% and of reproducibility 7.4-29.3%. The low 
repeatability in the method shows that the instrument was unreliable in giving the same result 
for the same concentration from one day to another, especially  for norFLU. Even the intra-day 
precision was rather low, again, especially for norFLU. This may be evidence for norFLU 
being more difficult to detect, but that hypothesis is outside the scope of this thesis.
3.3.2 Limits of detection and limits of quantification in water samples
 Instrumental limits of detection (LOD, and quantification (LOQ) were calculated as 3 and 
10 times the signal-to-noise ratio, respectively. The overall method detection limit  (MDL) was 
calculated by dividing LOD by Ee. Moreover, the practical quantitation limits (PQL), defined 
as 5 times MDL were calculated. All values for 4 µL of injection are presented in Table 4.
 Table 4.  LOD as 3 times the signal-to-noise ratio; LOQ as 10 times the signal-to-noise ratio; MDL as LOD 
divided by Ee; PQL as 5 times MDL. All values for water samples.
Analyte LOD (μg L-1) LOQ (μg L-1) MDL (ng L-1) PQL (ng L-1)
norFLU 1755 5851 280 1400
FLU 395 1316 130 650
SER 868 2893 260 1320
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 High limits of detection are, again, proof of rather poor instrumentation. LOD is especially 
high for norFLU, again, evidence of norFLU being hard to detect. Because of these poor 
values, norFLU was excluded from the exposure solution.
3.4 Application of the developed method
3.4.1 Enrichment factors in spiked cod samples and water samples
 The developed method was used to determine the enrichment factor, Ee, of norFLU, FLU 
and SER in spiked cod as 1642, 1805 and 1507, respectively. Enrichment factors in water 
were determined as 6287, 3020 and 3298 in norFLU, FLU and SER, respectively.
3.4.2 Determination of SSRIs in crucian carp samples
 The developed method was used to determine the concentration of norFLU, FLU and SER 
in exposed crucian carp and in the fish tank water where 51 µg L-1 was added to expose the 
fish. The results are presented in Table 5.
Table 5. Concentration analyte detected in exposed crucian carp and in the fish tank water, expressed both as CAe 
and CDi or µg g-1. 95% confidence, n=24 for fish samples, n=1 for water samples.
Analyte Conc. in fibre, CAe (μg L-1) Conc. in sample, CDi (μg L-1) Conc. in fish (μg g-1)
norFLU ND - ND
Fish FLU 31.7±4.9 - 1.70±0.28
SER 43.8±5.2 - 2.78±0.33
norFLU ND ND -
Water, 72 h FLU 46.7 15.5 -
SER 31.9 20.6 -
 In the exposed crucian carp FLU and SER was detected at concentrations 1.70±0.28 µg g-1 
and 2.78±0.33 µg g-1, respectively. The concentration of the analytes in the fish tank water 
was measured. At the point of exposure (Water, 0 h) no analytes were detected, and after 
3 days (Water, 72 h) concentrations of 15.5 µg L-1 and 20.6 µg L-1 of FLU and SER, 
respectively, were measured. This is to be compared with the 51 µg L-1 which were added, 
and signify  some adsorption or degradation losses. Unfortunately, no analytes were detected 
in the water, 0 h-sample. This may well be due to poor mixing in the fish tank. Because of 
poor repeatability  and high LOD (see sections 3.3.1 and 3.3.2) norFLU was not added to the 
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exposure solution. Nor was norFLU detected in the exposed fish. This may indicate a slow 
metabolism of FLU in fish.
 The developed method was also used to determine the concentration of norFLU, FLU and 
SER in unexposed crucian carp, no analytes were detected. This indicates a valid method.
4. Conclusion
 A direct  method to determine norFLU, FLU and SER in fish was developed based on HF-
LPME extraction and LC-MS analysis. The obtained enrichment factors for the analytes 
ranged 1500-1800 and 3000-6300 for exposed cod and water samples, respectively. In crucian 
carp, exposed to a 51 µg L-1 FLU and SER mixture for 72 h, the SSRIs were detected at 
concentrations 1.70±0.28 µg g-1 and 2.78±0.33 µg g-1, respectively. The FLU metabolite 
norFLU was not detected in the exposed fish. In the unexposed crucian carp, none of the 
analytes were detected. This method could be successfully applied to detect norFLU, FLU 
and SER in real fish samples.
5. Further work
Since the potential environmental impacts of PPCPs are not well studied, information 
concerning ecotoxicological risks and distribution in biota is needed. The elaboration and 
improvement of HF-LPME with LC-MS methodologies is one step  in the determination of 
trace level and ionisable analytes in environmental samples, especially  for samples with 
complex matrices.
 Because of the situation with the instruments, described in section 3.1.1, most  of the time 
allocated was spent on maintenance rather than development and optimisation. For this reason 
this method is in need of some refining. Primarily the exposure experiment should be carried 
out again and samples diluted to fit the linear range of the calibration curve. Because of the 
substantial matrix effect (section 3.2.1) the method of standard addition should be applied. In 
standard addition known quantities are added to the original sample, in this case a series of 
samples is spiked with increasing concentrations of standard. The initial concentration of the 
sample can subsequently be derived from the y-intercept of a spike vs. signal plot [47].
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